| Income Statement |
| Operating Expenses | 4.90M |
|
| Research and Development Expense | -531.44K |
| Selling, General and Administrative Expense | 5.43M |
| Operating Income | -4.90M |
| Net Income | -4.00M |
| Net Income Common Stock | -4.00M |
| Net Income Common Stock (USD) | -4.00M |
| Consolidated Income | -4.00M |
| Earnings per Basic Share | -0.09 |
| Earnings per Basic Share (USD) | -0.09 |
| Earnings per Diluted Share | -0.09 |
| Earning Before Interest & Taxes (EBIT) | -4.00M |
| Earning Before Interest & Taxes (USD) | -4.00M |
| Weighted Average Shares | 44.39M |
| Weighted Average Shares Diluted | 44.39M |
| Balance Sheet |
| Cash and Equivalents | 85.95M |
| Cash and Equivalents (USD) | 85.95M |
| Investments | 23.67M |
| Investments Current | 23.67M |
| Trade and Non-Trade Receivables | 527.15K |
| Current Assets | 110.50M |
| Total Assets | 110.50M |
| Current Liabilities | 1.60M |
| Total Liabilities | 1.60M |
| Accumulated Retained Earnings (Deficit) | -226.91M |
| Accumulated Other Comprehensive Income | -2.10M |
| Shareholders Equity | 108.90M |
| Shareholders Equity (USD) | 108.90M |
| Trade and Non-Trade Payables | 1.60M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 16.38K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -355.76K |
| Net Cash Flow from Investing | 3.84M |
| Net Cash Flow - Investment Acquisitions and Disposals | 3.84M |
| Net Cash Flow from Operations | -4.20M |
| Share Based Compensation | -633.93K |